These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


295 related items for PubMed ID: 33397366

  • 21. Regional reports for the subnational monitoring of measles elimination in Italy and the identification of local barriers to the attainment of the elimination goal.
    Adamo G, Sturabotti G, Baccolini V, de Soccio P, Prencipe GP, Bella A, Magurano F, Iannazzo S, Villari P, Marzuillo C.
    PLoS One; 2018; 13(10):e0205147. PubMed ID: 30356247
    [Abstract] [Full Text] [Related]

  • 22. Exploring landscape of measles vaccination coverage: A step towards measles elimination goal in India.
    Dhalaria P, Kumar P, Verma A, Priyadarshini P, Kumar Singh A, Tripathi B, Taneja G.
    Vaccine; 2024 Jun 20; 42(17):3637-3646. PubMed ID: 38704248
    [Abstract] [Full Text] [Related]

  • 23. Impact of an Intervention to Use a Measles, Rubella, and Polio Mass Vaccination Campaign to Strengthen Routine Immunization Services in Nepal.
    Wallace AS, Bohara R, Stewart S, Subedi G, Anand A, Burnett E, Giri J, Shrestha J, Gurau S, Dixit S, Rajbhandari R, Schluter WW.
    J Infect Dis; 2017 Jul 01; 216(suppl_1):S280-S286. PubMed ID: 28838201
    [Abstract] [Full Text] [Related]

  • 24. Accelerating measles elimination and strengthening routine immunization services in Guizhou Province, China, 2003-2009.
    Zuo S, Cairns L, Hutin Y, Liang X, Tong Y, Zhu Q, Zhang D, Lee LA, Strebel P, Quick L.
    Vaccine; 2015 Apr 21; 33(17):2050-5. PubMed ID: 25769207
    [Abstract] [Full Text] [Related]

  • 25. Progress Toward Measles Elimination - African Region, 2017-2021.
    Masresha BG, Hatcher C, Lebo E, Tanifum P, Bwaka AM, Minta AA, Antoni S, Grant GB, Perry RT, O'Connor P.
    MMWR Morb Mortal Wkly Rep; 2023 Sep 08; 72(36):985-991. PubMed ID: 37676836
    [Abstract] [Full Text] [Related]

  • 26. Comparative Distributional Impact of Routine Immunization and Supplementary Immunization Activities in Delivery of Measles Vaccine in Low- and Middle-Income Countries.
    Portnoy A, Jit M, Helleringer S, Verguet S.
    Value Health; 2020 Jul 08; 23(7):891-897. PubMed ID: 32762991
    [Abstract] [Full Text] [Related]

  • 27. Towards elimination of measles and rubella in Italy: Progress and challenges.
    Adamo G, Baccolini V, Massimi A, Barbato D, Cocchiara R, Di Paolo C, Mele A, Cianfanelli S, Angelozzi A, Castellani F, Salerno C, Isonne C, Bella A, Filia A, Del Manso M, Baggieri M, Nicoletti L, Magurano F, Iannazzo S, Marzuillo C, Villari P.
    PLoS One; 2019 Jul 08; 14(12):e0226513. PubMed ID: 31841530
    [Abstract] [Full Text] [Related]

  • 28. The challenge of achieving measles elimination in the eastern Mediterranean region by 2010.
    Gaafar T, Moshni E, Lievano F.
    J Infect Dis; 2003 May 15; 187 Suppl 1():S164-71. PubMed ID: 12721909
    [Abstract] [Full Text] [Related]

  • 29. A scorecard of progress towards measles elimination in 15 west African countries, 2001-19: a retrospective, multicountry analysis of national immunisation coverage and surveillance data.
    Wariri O, Nkereuwem E, Erondu NA, Edem B, Nkereuwem OO, Idoko OT, Agogo E, Enegela JE, Sesay T, Conde IS, Kaucley L, Awuah AA, Abdullahi S, Luce RR, Banda R, Nomhwange T, Kampmann B.
    Lancet Glob Health; 2021 Mar 15; 9(3):e280-e290. PubMed ID: 33607028
    [Abstract] [Full Text] [Related]

  • 30. Geospatial variation in measles vaccine coverage through routine and campaign strategies in Nigeria: Analysis of recent household surveys.
    Utazi CE, Wagai J, Pannell O, Cutts FT, Rhoda DA, Ferrari MJ, Dieng B, Oteri J, Danovaro-Holliday MC, Adeniran A, Tatem AJ.
    Vaccine; 2020 Mar 23; 38(14):3062-3071. PubMed ID: 32122718
    [Abstract] [Full Text] [Related]

  • 31. The impact of a prolonged ebola outbreak on measles elimination activities in Guinea, Liberia and Sierra Leone, 2014-2015.
    Masresha BG, Luce R, Weldegebriel G, Katsande R, Gasasira A, Mihigo R.
    Pan Afr Med J; 2020 Mar 23; 35(Suppl 1):8. PubMed ID: 32373259
    [Abstract] [Full Text] [Related]

  • 32. Optimization of frequency and targeting of measles supplemental immunization activities in Nigeria: A cost-effectiveness analysis.
    Zimmermann M, Frey K, Hagedorn B, Oteri AJ, Yahya A, Hamisu M, Mogekwu F, Shuaib F, McCarthy KA, Chabot-Couture G.
    Vaccine; 2019 Sep 24; 37(41):6039-6047. PubMed ID: 31471147
    [Abstract] [Full Text] [Related]

  • 33. Immunization in the Eastern Mediterranean Region: some signs of post-COVID-19 recovery, but more work ahead.
    Hasan Q, Hutin YF, Hajjeh R.
    East Mediterr Health J; 2023 Sep 09; 29(9):681-683. PubMed ID: 37776128
    [Abstract] [Full Text] [Related]

  • 34. Added value of the measles-rubella supplementary immunization activity in reaching unvaccinated and under-vaccinated children, a cross-sectional study in five Indian districts, 2018-20.
    Prosperi C, Thangaraj JWV, Hasan AZ, Kumar MS, Truelove S, Kumar VS, Winter AK, Bansal AK, Chauhan SL, Grover GS, Jain AK, Kulkarni RN, Sharma SK, Soman B, Chaaithanya IK, Kharwal S, Mishra SK, Salvi NR, Sharma NP, Sharma S, Varghese A, Sabarinathan R, Duraiswamy A, Rani DS, Kanagasabai K, Lachyan A, Gawali P, Kapoor M, Chonker SK, Cutts FT, Sangal L, Mehendale SM, Sapkal GN, Gupta N, Hayford K, Moss WJ, Murhekar MV.
    Vaccine; 2023 Jan 09; 41(2):486-495. PubMed ID: 36481106
    [Abstract] [Full Text] [Related]

  • 35. Effect of evidence updates on key determinants of measles vaccination impact: a DynaMICE modelling study in ten high-burden countries.
    Fu H, Abbas K, Klepac P, van Zandvoort K, Tanvir H, Portnoy A, Jit M.
    BMC Med; 2021 Nov 17; 19(1):281. PubMed ID: 34784922
    [Abstract] [Full Text] [Related]

  • 36. Epidemiology of measles cases, vaccine effectiveness, and performance towards measles elimination in The Gambia.
    Sowe A, Njie M, Sowe D, Fofana S, Ceesay L, Camara Y, Tesfaye B, Bah S, Bah AK, Baldeh AK, Dampha BD, Baldeh SN, Touray A.
    PLoS One; 2021 Nov 17; 16(10):e0258961. PubMed ID: 34673828
    [Abstract] [Full Text] [Related]

  • 37. Progress Toward Measles Elimination - Nepal, 2007-2014.
    Khanal S, Sedai TR, Choudary GR, Giri JN, Bohara R, Pant R, Gautam M, Sharapov UM, Goodson JL, Alexander J, Dabbagh A, Strebel P, Perry RT, Bah S, Abeysinghe N, Thapa A.
    MMWR Morb Mortal Wkly Rep; 2016 Mar 04; 65(8):206-10. PubMed ID: 26937619
    [Abstract] [Full Text] [Related]

  • 38. Progress toward measles elimination in the Eastern Mediterranean Region.
    Naouri B, Ahmed H, Bekhit R, Teleb N, Mohsni E, Alexander JP.
    J Infect Dis; 2011 Jul 04; 204 Suppl 1():S289-98. PubMed ID: 21666176
    [Abstract] [Full Text] [Related]

  • 39. Progress Toward Measles Elimination - Bangladesh, 2000-2016.
    Khanal S, Bohara R, Chacko S, Sharifuzzaman M, Shamsuzzaman M, Goodson JL, Dabbagh A, Kretsinger K, Dhongde D, Liyanage J, Bahl S, Thapa A.
    MMWR Morb Mortal Wkly Rep; 2017 Jul 21; 66(28):753-757. PubMed ID: 28727678
    [Abstract] [Full Text] [Related]

  • 40. Contribution of polio eradication initiative to strengthening routine immunization: Lessons learnt in the WHO African region.
    Anya BM, Moturi E, Aschalew T, Carole Tevi-Benissan M, Akanmori BD, Poy AN, Mbulu KL, Okeibunor J, Mihigo R, Zawaira F.
    Vaccine; 2016 Oct 10; 34(43):5187-5192. PubMed ID: 27396492
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 15.